SUMMARY The efficiency of an immunoperoxidase serological assay and culture of Chlamydia trachomatis were compared in 127 women seeking first trimester abortion. Serum IgG and IgA antibodies specific for C trachomatis wer.e detected by a single serovar (L2) inclusion immunoperoxidase assay (IPA). Eighty (63%) women were seropositive for chlamydial IgG and 31 (24%) for IgA antibodies. C trachomatis was isolated from 21 of 127 (17%) women. Twenty of the 80 women (25%) seropositive for specific IgG antibodies and one of 47 (2%) patients without these antibodies were culture positive (p < 0-001). Compared with isolation, chlamydial antibodies at a titre of > 16 showed high sensitivity and negative predictive value (95% and 98%, respectively), but low specificity and efficiency (43% and 52%, respectively). Chlamydial IgA antibodies at a titre of > 8 showed low sensitivity (52%), but a higher specificity, negative predictive value, and efficiency of 81%, 90%, and 76%, respectively. C trachomatis IgG antibodies at a titre of 16 as determined by IPA can be used as an efficient negative exclusion marker for active chlamydial infection in screening women seeking abortion. Postabortal salpingitis may complicate postoperative recovery in about 20% of women infected with C trachomatis.' To avoid this complication screening for C trachomatis by direct immunofluorescence and culture isolation has recently gained wider application for women wanting an abortion. Although culture is the standard reference method, it is costly, time consuming, and requires considerable experience. The results may also arrive too late and therefore be oflittle help in deciding on appropriate management. Direct detection methods are speedier, but they, too, require expensive equipment, skill, and may be less sensitive than culture.2 In this study we compared the efficiency of a new and sensitive serological method with the standard cell culture. The results of cell culture were correlated with serology for specific chlamydial IgG and IgA antibodies by the single serovar (L2) IPA.
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Patients and methods
One hundred and twenty seven women presenting for first trimester abortion were included in the study. The Accepted for publication 14 July 1987 study population, age distribution, sampling technique, transport and culture of C trachomatis have been described elsewhere.'
The detection of IgG and IgA antibodies specific for C trachomatis was carried out by a single serovar (L2) immunoperoxidase assay (IPA, "Ipazyme Chlamydia", Savyon Diagnostics Ltd, Beer Sheva, Israel), according to a previously described method.3
Titres of 16 and 8 were regarded as seropositive in the IgG and IgA tests, respectively.
The analysis was based on Bayes' theorem,4 further defined by Galen and Gambino.5 Sensitivity was defined as the percentage of seropositive tests in patients with C trachomatis positive cultures and specificity as the percentage of seronegative tests in patients with negative cultures. The positive predictive value was defined as the probability that a patient who had a positive serological test actually yielded C trachomatis on culture. The negative predictive value was the probability that a seronegative patient produced a negative culture. With data on test sensitivity, specificity, and the prevalence of C trachomatis isolates among patients, the positive predictive value can readily be determined from the equation, or in terms of numbers of true positive and false positive results: Table I shows that 63% of the patients were seropositive by the IPA test, specific for chlamydial IgG. C trachomatis was isolated from 20 of the 80 seropositive women and one of the 47 seronegative women. This difference was significant (p < 0-0 1). Table 2 shows the results of specific IgA detection compared with culture. C trachomatis was isolated from 11 of the 31 seropositive women and 10 of the 96 seronegative women. This difference was significant (p <0-01). The prevalence of chlamydial IgA was 24% at a 1/8 dilution of serum. All sera positive for IgA were also seropositive for IgG (titre of > 16). Of those women with antibodies specific for both IgG and patients were asymptomatic women, in whom the presence of serum antibodies could not be regarded as an effective marker of a mild mucosal infection. Thus for this group of patients, the IgG test gave a higher sensitivity and lower false negative rate and should therefore be regarded as a better screening test than the IgA test. The specificity of the IgG test was only 43%. This can be explained as serology was evaluated by isolating C trachomatis from the genital tract. Chlamydial IgG antibodies detected by IPA, determined by C trachomatis (L2) infected cells as antigen, have a broad reactivity. Specific IgG antibodies may indicate ongoing or past chlamydial infection in sites other than the genitourinary tract.'8 This may explain the dis--crepancy in the detection rates between serology and culture. The development of a serological technique of comparable sensitivity, which detects only genital strains of C trachomatis, could be valuable. Furthermore, the isolation of C trachomatis in cell culture is less than 100% sensitive, although it is thought to be the "golden standard" by which other methods are evaluated. In active infections, therefore, IgG may be present and yet cell culture may be negative. According to Robertson et al.,2' an indirect fluorescence test with C trachomatis L2 as antigen showed that there were almost twice as many seropositive results among women seeking abortion compared with women who used barrier contraception and did not become pregnant.
Chlamydial infections are treatable, but the complications of postoperative chlamydial disease can be serious.' Chlamydial salpingitis and endometritis with subsequent infertility can be prevented by early detection and treatment. Rapid diagnosis can be facilitated by the IPA technique which can be read with a light microscope and easily performed in every laboratory. Its high sensitivity, negative predictive value, speed and simplicity make it an adjunct to existing diagnostic procedures. The test can therefore be used to screen women who want an abortion and can thus prevent unnecessary use of antibiotics in seronegative women. The use of preoperative antibiotics without screening could be a simpler and less expensive approach in a population with a high incidence of chlamydial infections, but objections could be raised against treatment without screening in populations with a low incidence as many patients would be treated unnecessarily.
Nettleman et al suggest that the most cost effective approach is to serotest all patients and treat those who are seropositive. Deciding whom to treat would then be based on relative risk and not direct evidence of infection. Because of its high sensitivity and negative predictive value, serology would effectively exclude women not requiring direct testing and at the same time it could lead to a more careful follow up of the seropositive women. The advantages and disadvantages of the serological testing compared with those of culture have to be weighed against each other.
If direct detection of C trachomatis is to be widely adopted then the development of less complex, more sensitive, and rapid techniques is necessary to decide which seropositive patients harbour C trachomatis in their genital secretions.
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